Post-Treatment Lyme Disease Syndrome (PTLDS)

Post-Treatment Lyme Disease Syndrome describes persistent or relapsing fatigue, musculoskeletal pain, cognitive difficulties, and mood changes lasting more than six months after appropriate antibiotic treatment for Lyme disease. It is not the same as untreated or disseminated infection; ongoing symptoms may reflect immune dysregulation, tissue damage, or nervous system changes.

Symptoms

Diagnosis

Treatment Principles

Symptom Management

Lifestyle & Self-Care

Living with PTLDS

Complications

Research & Future Directions

Scientists study immune signatures, persistent antigen fragments, microglial activation, and overlap with other post-infectious syndromes (e.g., Long COVID). Precision biomarkers may eventually guide targeted therapies.

Experimental & Emerging Treatments

Track PTLDS with Diagnoza.care

Navigate Life After Lyme – Log symptoms, activity levels, sleep, medications, therapies, and mental health check-ins, schedule follow-ups with infectious disease, rheumatology, neurology, and pain specialists, capture side effects, and let the AI companion correlate triggers with relapses.
Medical Disclaimer: Informational only. Work with clinicians experienced in Lyme disease and post-infectious syndromes for individualized evaluation and care. Sources: Centers for Disease Control and Prevention, Infectious Diseases Society of America, Global Lyme Alliance